• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

251.9100 USD 2.1500 0.85%

As of 20:10:00 ET on 07/28/2014.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 253.2900 High - Low: 254.0590 - 249.9400 Primary Exchange: NASDAQ GM
Volume: 954,279 52-Week Range: 187.0500 - 275.4000 Beta vs XNBI: 1.0005

ETF Chart for IBB

No chart data available.
  • IBB:US 252.0300
  • 1D
  • 1M
  • 1Y
254.0600
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2014-07-28) 251.9900
Assets (M) (on 2014-07-28) 5,191.0540
Shares out (M) 20.60
Market Cap (M) 5,189.35
% Premium -0.03
Average 52-Week % Premium 0.0000
Fund Leveraged N

Dividends for IBB

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.16%

Performance for IBB

1-Month -1.88% 1-Year +28.45%
3-Month +13.11% 3-Year +34.82%
Year To Date +11.11% 5-Year +26.27%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 07/25/2014
Name Position Value % of Total
Celgene Corp 5,124,708 446,669,549 8.564%
Gilead Sciences Inc 4,828,502 433,792,620 8.317%
Amgen Inc 3,380,672 415,281,748 7.963%
Biogen Idec Inc 1,227,804 411,866,852 7.897%
Alexion Pharmaceuticals Inc 2,155,193 360,003,439 6.903%
Vertex Pharmaceuticals Inc 2,713,286 259,797,135 4.981%
Illumina Inc 1,238,937 211,895,395 4.063%
Mylan Inc/PA 3,933,825 203,536,106 3.903%
Regeneron Pharmaceuticals Inc 638,722 193,590,251 3.712%
Endo International PLC 1,787,002 122,463,247 2.348%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil